Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > BIIB Biogen > Detailed Quotes

BIIB Biogen

Watchlist
283.630
-3.890-1.35%
Close  02/03 16:00 ET
283.500
-0.130-0.05%
Post Mkt Price 02/03 17:02 ET
High
291.100
Open
288.570
Turnover
224.90M
Low
282.520
Pre Close
287.520
Volume
789.15K
Market Cap
40.84B
P/E(TTM)
14.49
52wk High
311.880
Shares
144.00M
P/E(Static)
27.27
52wk Low
187.160
Float Cap
40.72B
Bid/Ask %
0.00%
Historical High
480.180
Shs Float
143.56M
Volume Ratio
0.96
Historical Low
2.625
Dividend TTM
--
Div Yield TTM
--
P/B
3.20
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.55%
Amplitude
2.98%
Avg Price
284.995
Lot Size
1
Float Cap
40.72B
Bid/Ask %
0.00%
Historical High
480.180
Shs Float
143.56M
Volume Ratio
0.96
Historical Low
2.625
Dividend TTM
--
P/B
3.20
Dividend LFY
--
Turnover Ratio
0.55%
Amplitude
2.98%
Avg Price
284.995
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. It offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for the treatment of multiple sclerosis, SPINRAZA for the treatment of spinal muscular atrophy, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.
CEO: Mr. Christopher A. Viehbacher
Market: NASDAQ
Listing Date: 09/17/1991
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist